News & Blog

Tag Archives: GBM

Brain Tumor Researcher Spotlight: Dr. David Louis

Dr. David Louis, Pathologist-in-Chief at Massachusetts General Hospital (MGH) and Benjamin Castleman Professor of Pathology at Harvard Medical School, is an internationally recognized expert in brain tumor pathology and molecular genetics.

A Response to the Results of Avastin Clinical Trials for Glioblastoma Treatment

National Brain Tumor Society comments on the recently announced results of the AVAglio and RTOG clinical trials.